Found: 4
Select item for more details and to access through your institution.
PII-64.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 2, p. P53, doi. 10.1016/j.clpt.2005.12.189
- By:
- Publication type:
- Article
Safety, tolerability, and pharmacokinetics of TAS-108 in normal healthy post-menopausal female subjects: a phase I study on single oral dose [corrected] [published erratum appears in J CLIN PHARM THER 2006 Apr;31(2):204].
- Published in:
- 2005
- By:
- Publication type:
- Journal Article
Safety, tolerability, and pharmacokinetics of TAS-108 in normal healthy post-menopausal female subjects: a phase I study on single oral dose.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2005, v. 30, n. 5, p. 459, doi. 10.1111/j.1365-2710.2005.00673.x
- By:
- Publication type:
- Article
The expression of murine cutaneous late phase reaction requires both IgE antibodies and CD4 T cells.
- Published in:
- Clinical & Experimental Allergy, 1997, v. 27, n. 2, p. 225, doi. 10.1111/j.1365-2222.1997.tb00697.x
- By:
- Publication type:
- Article